Markets
Tech
Media
Success
Video
Markets
Premarkets
Dow
After-Hours
Market Movers
Fear & Greed
World Markets
Investing
Markets Now
Before the Bell
Leading Indicator
Global Energy Challenge
Economy
Energy
Tech
Innovate
Gadget
Mission: Ahead
Upstarts
Business Evolved
Work Transformed
Innovative Cities
Unhackable
Media
Reliable Sources
Success
Boss Files
Fresh Money
Cars
Homes
Biz + Leisure
Center Piece
Perspectives
Video
International
Switzerland
India
Davos
Passion to Portfolio
On: Germany
More
Newsletters
About Us
Accessibility and CC
U.S.
World
Politics
Business
Opinion
Health
Entertainment
Tech
Style
Travel
Sports
Video
Shop
VR
More...
Follow CNN Business
Do Not Sell
Puma Biotechnology Inc
(NASDAQ:PBYI)
3.75
Delayed Data
As of
3:52pm ET
-0.15
/
-3.85%
Today’s Change
2.13
Today
|||
52-Week Range
5.16
-11.35%
Year-to-Date
Quote
Profile
News
Charts
Forecasts
Financials
Shareholders
Competitors
Latest PBYI News
|
Press Releases
AstraZeneca (AZN) to Discontinue Two Studies on Lokelma
11:27am / Zacks.com - Paid Partner Content
Immunovant (IMVT) Up on Positive Initial IMVT-1402 MAD Study Data
Nov 29 / Zacks.com - Paid Partner Content
Acadia (ACAD) Begins Study on ACP-101 for Hyperphagia in PWS
8:57am / Zacks.com - Paid Partner Content
SpringWorks (SWTX) Rises on FDA Nod for Desmoid Tumor Drug
Nov 29 / Zacks.com - Paid Partner Content
Here Is Why Bargain Hunters Would Love Fast-paced Mover Puma Biotech (PBYI)
8:50am / Zacks.com - Paid Partner Content
AbbVie (ABBV) Lymphoma Drug Gets FDA Breakthrough Therapy Tag
Nov 28 / Zacks.com - Paid Partner Content
Seagen's (SGEN) Combo Drug Expanded-Use sBLA Gets Priority Tag
7:42am / Zacks.com - Paid Partner Content
Xenon (XENE) Up on Top-Line Data From MDD Drug Phase II Study
Nov 28 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Posts Encouraging Data From Lung Cancer Study
Nov 30 / Zacks.com - Paid Partner Content
TC BioPharm (TCBP) Falls Despite FDA Clearing IND for AML Drug
Nov 28 / Zacks.com - Paid Partner Content
FDA Accepts Karuna's (KRTX) NDA Filing for Schizophrenia Drug
Nov 30 / Zacks.com - Paid Partner Content
GSK's Blenrep Combo Meets PFS Endpoint in Head-to-Head Study
Nov 27 / Zacks.com - Paid Partner Content
Adaptimmune (ADAP) Rises as GSK Transfers T-Cell Therapy IND
Nov 30 / Zacks.com - Paid Partner Content
Freeline (FRLN) Shares Rise on Merger Agreement With Syncona
Nov 23 / Zacks.com - Paid Partner Content
BioVie (BIVI) Falls 61% Despite Upbeat Alzheimer's Study Data
Nov 30 / Zacks.com - Paid Partner Content
Immix (IMMX) CAR-T Therapy IND Cleared by FDA, Stock Down
Nov 22 / Zacks.com - Paid Partner Content
4 Top-Performing Liquid Stock Picks for Robust Returns
Nov 30 / Zacks.com - Paid Partner Content
Here's Why You May Invest in Puma Biotechnology (PBYI) Stock
Nov 20 / Zacks.com - Paid Partner Content
Acadia (ACAD) Begins Alzheimer's Disease Psychosis Study (Revised)
Nov 30 / Zacks.com - Paid Partner Content
PBYI vs. TECH: Which Stock Is the Better Value Option?
Nov 20 / Zacks.com - Paid Partner Content
Emergent (EBS) Gets $75M BARDA Contract for Anthrax Vaccine
Nov 29 / Zacks.com - Paid Partner Content